Ye Weiguo's Form 4 filing
Gyre Therapeutics, Inc. (GYRE) · filed Jun 8, 2026
- Accession no.
- 0001140361-26-024449
- Filed
- Jun 8, 2026
- Trade date
- Jun 4-5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $218.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ye WeiguoCIK 0001985496 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | MOption exerciseAcquired | +19,575 | $0.75 | +$14,681.25 | 719,575 | Direct | |
| Jun 4, 2026 | Common Stock | SSaleDisposed | −19,575 | $6.13 | −$119,994.75 | 700,000 | Direct | |
| Jun 5, 2026 | Common Stock | MOption exerciseAcquired | +15,401 | $0.75 | +$11,550.75 | 715,401 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −15,401 | $6.40 | −$98,566.4 | 700,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | MOption exerciseDisposed | −19,575 | $0.00 | $0 | 877,820 | Direct | |
| Jun 5, 2026 | Common Stock | MOption exerciseDisposed | −15,401 | $0.00 | $0 | 862,419 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.